Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome

BACKGROUND: Brain metastases (BM) are rarely reported in patients with neuroendocrine carcinoma (NEC) of non-lung origin and neuroendocrine tumors (NET) of the gastroenteropancreatic (GEP) or bronchopulmonary system. However, symptomatic brain metastases are associated with dismal prognosis, so earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Krug, Sebastian, Teupe, Freya, Michl, Patrick, Gress, Thomas M., Rinke, Anja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469052/
https://www.ncbi.nlm.nih.gov/pubmed/30991982
http://dx.doi.org/10.1186/s12885-019-5559-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469052/
https://www.ncbi.nlm.nih.gov/pubmed/30991982
http://dx.doi.org/10.1186/s12885-019-5559-7

Ejemplares similares